- Investing Ideas
- Australian Pharmaceuticals & Biotech Nano Cap Stocks
Australian Pharmaceuticals & Biotech Nano Cap Stocks
Results
6
Stocks with a market cap under US$50M.
6 companies
Botanix Pharmaceuticals
Market Cap: AU$57.4m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.021
7D
5.0%
1Y
-86.5%
Little Green Pharma
Market Cap: AU$56.3m
Produces and sells cannabis-based medicinal products across Australia and Europe.
LGP
AU$0.068
7D
-6.8%
1Y
-45.6%
Medical Developments International
Market Cap: AU$55.2m
Provides emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.49
7D
-4.9%
1Y
-20.3%
Radiopharm Theranostics
Market Cap: AU$43.4m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.01
7D
-16.7%
1Y
-63.0%
Trajan Group Holdings
Market Cap: AU$27.5m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.18
7D
-5.3%
1Y
-80.6%
Vitura Health
Market Cap: AU$17.2m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.026
7D
4.0%
1Y
-61.8%